New typhoid conjugate vaccine provides longer lasting protection for younger children
Gavi, the Vaccine Alliance has approved US$ 85 million to help people in developing countries receive an innovative protection against typhoid fever.
Personas en este video
No hay usuarios etiquetados en este video